Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Gross Margin (2016 - 2024)

Historic Gross Margin for Regenxbio (RGNX) over the last 11 years, with Q4 2024 value amounting to 70.22%.

  • Regenxbio's Gross Margin rose 208100.0% to 70.22% in Q4 2024 from the same period last year, while for Dec 2024 it was 59.72%, marking a year-over-year increase of 9500.0%. This contributed to the annual value of 59.72% for FY2024, which is 9500.0% up from last year.
  • According to the latest figures from Q4 2024, Regenxbio's Gross Margin is 70.22%, which was up 208100.0% from 48.81% recorded in Q3 2024.
  • Over the past 5 years, Regenxbio's Gross Margin peaked at 94.22% during Q4 2021, and registered a low of 29.26% during Q1 2022.
  • Its 5-year average for Gross Margin is 62.32%, with a median of 58.19% in 2022.
  • As far as peak fluctuations go, Regenxbio's Gross Margin crashed by -450500bps in 2022, and later surged by 492500bps in 2023.
  • Regenxbio's Gross Margin (Quarter) stood at 52.17% in 2020, then soared by 81bps to 94.22% in 2021, then crashed by -37bps to 59.22% in 2022, then fell by -17bps to 49.41% in 2023, then skyrocketed by 42bps to 70.22% in 2024.
  • Its Gross Margin stands at 70.22% for Q4 2024, versus 48.81% for Q3 2024 and 52.55% for Q2 2024.